Bioreactors Market Statistics, 2030
The global bioreactors market was valued at $2,615.4 million in 2020, and is estimated to reach $7,328.4 million by 2030, growing at a CAGR of 10.7% from 2021 to 2030. Bioreactors are defined as a manufacturing device or vessel in which biological reactions are performed and are used to grow various organisms such as yeast, bacteria, or animal cell under appropriate environment. They maintain a sustainable environment for cell growth and product formation. Bioreactors are used in pharmaceutical and biotechnology industry in order to produce vaccines, antibodies or biologic products. They are also used in industrial process in order to cultivate organism under controlled condition and produce pharmaceutical products for treatment of chronic disease.
Growth of the global bioreactors market is majorly driven by an increase in demand for monoclonal antibiotics; rise in funding from private & government organizations for development of vaccine; surge in demand for single-use bioreactors; and increase in development in the pharmaceutical and biotechnology industry. For instance, in 2019, Applikon Biotechnology, a manufacturing company specialized in upstream bioprocess equipment, launched single use AppliFlex ST lab-scale bioreactor, which is a fully customized single use bioreactor, and is provided with pre sterilized and “ready to go” system in order to save time while cell culture set up. In addition, rise in technological development for advanced bioreactor and advancement in equipment design for bioprocessing fuels the bioreactors market growth during the forecast period.
Moreover, in 2021, Beckman Coulter Life Science, a Danaher corporation engaged in healthcare development, launched new BioLector XT Microbioreactor, which enable high-throughput strain screening, feeding strategy optimization and monitoring of cultivation parameters. It also possesses the ability to collect high quality data in short span of time by the use of least amount of manual mechanism. Thus, presence of key players in manufacturing of advanced bioreactors, rise in R&D activities for cell culture and microbial application and increase in number of clinical and pre-clinical trial study, surge the demand for bioreactors and propel the growth of the bioreactors market. However, high cost associated with bioreactors is expected to restrict the bioreactors market growth during the forecast period.
Bioreactors Market Segmentation
The bioreactors market is segmented on the basis of type, usage, scale, control type and region. By type, the market is categorized into glass, stainless steel, and single-use. By usage, the market is divided into lab-scale production, pilot-scale production, and full-scale production. On the basis of scale, the market is classified into 5L-20L, 20L-200L, 200L-1500L and above 1500L. By control type, the market is fragmented into manual and automated (MFCs).
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
By Type
Depending on type, the single use segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in demand for biologic drugs, initiatives taken by the government for the development of the pharmaceutical sector and advancement in R&D activities for production of vaccine. However, the glass segment is expected to witness considerable market growth during the forecast period, due to surge in demand for monoclonal antibiotics, advancement in technology for advanced bioreactor and increase in funding for biotechnological segments.
By Type
Single Use segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.
By Usage
On the basis of usage, the pilot-scale production segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of chronic disease, development in pharmaceutical and biotechnology industry and increase in number for clinical and pre-clinical trial study. However, the full-scale production segment is expected to witness considerable growth during the forecast period, owing to advancement in R&D activities for vaccine development and surge in adoption of advanced bioreactors.
By Usage
Pilot-scale Production segment is projected as one of the most lucrative segment.
By Control Type
On the basis of control type, the automated segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of chronic disease, surge in adoption of cell culture technique and advancement in R&D activities for the production of personalized medicine. However, the manual segment is expected to witness considerable growth during the forecast period, owing to increase in prevalence of chronic disease, growth in the pharmaceutical industry for cell culture application, and increase in number of unemployment.
By Control Type
Automated segment is projected as one of the most lucrative segment.
By Region
North America accounted for a major share in the bioreactors market in 2020, and is expected to maintain its dominance during the forecast period, owing to rise in prevalence of chronic diseases, the presence of key players in manufacturing advanced bioreactors, and advancements in R&D in biomedical research in the region. However, Asia-Pacific is expected to register highest CAGR of 12.3% from 2021 to 2030, owing to increase in prevalence of chronic diseases, increase in demand for novel biologic drugs, and rise in number of pharmaceutical industry.
By Region
North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.
Competition Analysis
Key players operating in the global bioreactors market include BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, and Thermo Fisher Scientific, Inc.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the bioreactors market, and the current trends and future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing bioreactors market opportunities.
- Extensive analysis of the bioreactors market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the bioreactors market.
Key Market Segments
By Type
- Glass
- Stainless Steel
- Single-Use
By Usage
- Lab-Scale Production
- Pilot-Scale Production
- Full-Scale Production
By Scale
- 5L-20L
- 20L-200L
- 200L-1500L
- Above 1500L
By Control Type
- Manual
- Automated
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- BBI-Biotech GmbH
- Bioengineering AG
- Danaher Corporation
- Eppendorf AG
- Getinge
- Infors HT
- Merck KGAA
- Sartorius AG
- Solaris Biotech Solutions
- Thermo Fisher Scientific, Inc.
Bioreactors Market, by Type Report Highlights
| Aspects | Details |
 By TYPE |
|
 By USAGE |
|
 By SCALE |
|
 By CONTROL TYPE |
|
 By Region |
|
 Key Market Players | THERMO FISHER SCIENTIFIC, INC., .BIOENGINEERING AG., INFORS HT, MERCK KGAA, EPPENDORF AG, GETINGE, SARTORIUS AG, SOLARIS BIOTECH SOLUTIONS, BBI-BIOTECH GmbH, DANAHER CORPORATION |
Analyst Review
According to analyst perspective, the growth of the bioreactors market is attributed to factors such as technological advancements in R&D for development of vaccines; rise in prevalence of chronic diseases such as cancer, cystic fibrosis, and heart disease; increase in funds from private and government organizations for biomedical research, and surge in demand for monoclonal antibodies and personalized medicine. The bioreactors market gains interest of biotechnology & pharma companies, owing to surge in demand for vaccines and regenerative medicine. This leads to increase in adoption of bioreactors. Moreover, the market has gained high traction in biotechnology and pharmaceutical company in recent years as these devices are used in cell culture and microbial application.
Further, North America is expected to witness highest growth, in terms of revenue, owing to rise in prevalence of chronic diseases, the presence of key players, and advancements in R&D activities for vaccine development.
Asia-Pacific was the second-largest contributor to the market in 2020, and is expected to register fastest CAGR during the forecast period, owing to increase in prevalence of chronic diseases, rise in funds by private and government organization for biomedical research, increase in demand for novel drugs, and rise in number of pharmaceutical industry.
In addition, the high cost associated with bioreactors is anticipated to restrain the market growth during the forecast period.
The total market value of bioreactors Market is $2,615.4 million in 2020.
The forecast period in the report is from 2021 to 2030
The market value of bioreactors Market in 2021 was $2,932.4 million
The base year for the report is 2020.
Yes, bioreactors companies are profiled in the report
The top companies that hold the market share in bioreactors market are BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, Thermo Fisher Scientific, Inc.
No, there is no value chain analysis provided in the bioreactors Market report
The key trends in the bioreactors Market are advancement in R&D for vaccine development, increase in prevalence of chronic disease, surge in demand for monoclonal antibiotics, and development of pharmaceutical and biotechnology industry.
Loading Table Of Content...
